Preview Mode Links will not work in preview mode

MPR Weekly Dose

Mar 30, 2021

With three FDA authorized vaccines being administered throughout the US, but new variants growing in number, we are at a crucial moment in the COVID-19 pandemic. 

To get a better understanding of how the future months could unfold, MPR sat down with Dr Joshua Barocas, an assistant professor of medicine at the Boston...


Mar 18, 2021

This week we have new study data on the real-world effectiveness of the Pfizer-BioNTech vaccine; The number of Americans who are completing both vaccine doses; A vaccine trial that has started in children; And an approval in acute bacterial skin and skin structure infections. 


Mar 12, 2021

This week it's all COVID related news; There’s new CDC guidance for those who are vaccinated; A first over the counter test that doesn’t require a prescription; Nasopharyngeal povidone iodine and the combo of Bamlanivimab-Etesevimab is assessed; And there’s reports of vaccine local reactions.


Mar 5, 2021

This week we have news of an indication for the cancer treatment, Keytruda, being withdrawn; Janssen’s single dose vaccine gains Emergency Authorization; There’s findings on the effectiveness of Ivermectin as a therapy for mild COVID-19; And devices to treat migraine and prevention of sub-concussive head impacts are...